Table1.

Baseline demographic and clinical findings of the enrolled patients

Pt.nr./ gender	Age at drug start	Epilepsy	SEGA	SEN	Hypopigmented macules	Angiofibroma	AML	Cardiac lesions
1/M	19	Yes	Yes	Yes	Yes	Yes	Yes	No
2/F	13	Yes	Yes	No	Yes	Yes	Yes	No
3/F	8	Yes	Yes	Yes	Yes	Yes	Yes	Yes
4/M	10	Yes	Yes	Yes	Yes	No	Yes	No
5/F	14	Yes	Yes	Yes	Yes	Yes	Yes	No
6/F	8	Yes	Yes	Yes	Yes	Yes	No	No
7/F	10	Yes	Yes	Yes	Yes	Yes	No	No
8/M	7	Yes	Yes	Yes	Yes	Yes	Yes	Yes
9/M	10	Yes	Yes	Yes	Yes	Yes	Yes	No
10/M	9	Yes	Yes	Yes	Yes	Yes	No	No
11/F	10	Yes	Yes	Yes	Yes	Yes	Yes	Yes
12/F	6	Yes	Yes	Yes	Yes	Yes	Yes	Yes
13/M	9	Yes	Yes	Yes	Yes	Yes	No	No
14/F	7	Yes	Yes	Yes	Yes	Yes	Yes	Yes

AML, Angiomyolipoma ; F, Female ; M, Male ; mo,months ; nr., Number ; Pt., Patient ; SEGA, Subependymal Giant Cell Astrocytoma ; SEN, Sub Ependymal Nodules.